Latest Samsara BioCapital, LLC Stock Portfolio
Samsara BioCapital, LLC Performance:
2024 Q3: -3.07%YTD: -17.21%2023: 20.78%
Performance for 2024 Q3 is -3.07%, and YTD is -17.21%, and 2023 is 20.78%.
About Samsara BioCapital, LLC and 13F Hedge Fund Stock Holdings
Samsara BioCapital, LLC is a hedge fund based in PALO ALTO, CA. On 26-Apr-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $1.4 Billions. In it's latest 13F Holdings report, Samsara BioCapital, LLC reported an equity portfolio of $520.3 Millions as of 30 Sep, 2024.
The top stock holdings of Samsara BioCapital, LLC are , , SRRK. The fund has invested 15.7% of it's portfolio in CARGO THERAPEUTICS INC and 11.8% of portfolio in MINERALYS THERAPEUTICS INC.
The fund managers got completely rid off IGM BIOSCIENCES INC (IGMS) stocks. They significantly reduced their stock positions in JANUX THERAPEUTICS INC (JANX), VERONA PHARMA PLC (VRNA) and DAY ONE BIOPHARMACEUTICALS I (DAWN). Samsara BioCapital, LLC opened new stock positions in ALUMIS INC. The fund showed a lot of confidence in some stocks as they added substantially to JASPER THERAPEUTICS INC (JSPR).
The top stock holdings of Samsara BioCapital, LLC are , , SRRK. The fund has invested 15.7% of it's portfolio in CARGO THERAPEUTICS INC and 11.8% of portfolio in MINERALYS THERAPEUTICS INC.
The fund managers got completely rid off IGM BIOSCIENCES INC (IGMS) stocks. They significantly reduced their stock positions in JANUX THERAPEUTICS INC (JANX), VERONA PHARMA PLC (VRNA) and DAY ONE BIOPHARMACEUTICALS I (DAWN). Samsara BioCapital, LLC opened new stock positions in ALUMIS INC. The fund showed a lot of confidence in some stocks as they added substantially to JASPER THERAPEUTICS INC (JSPR).
Samsara BioCapital, LLC Annual Return Estimates Vs S&P 500
Our best estimate is that Samsara BioCapital, LLC made a return of -3.07% in the last quarter. In trailing 12 months, it's portfolio return was 14.48%.
New Buys
| Ticker | $ Bought |
|---|---|
| alumis inc | 34,886,200 |
| artiva biotherapeutics inc | 4,506,240 |
| bicara therapeutics inc | 891,450 |
New stocks bought by Samsara BioCapital, LLC
Additions
| Ticker | % Inc. |
|---|---|
| jasper therapeutics inc | 11.36 |
Additions to existing portfolio by Samsara BioCapital, LLC
Reductions
| Ticker | % Reduced |
|---|---|
| janux therapeutics inc | -50.00 |
| verona pharma plc | -43.82 |
| day one biopharmaceuticals i | -25.00 |
| arcellx inc | -22.04 |
| eliem therapeutics inc | -20.00 |
| contineum therapeutics inc | 0.00 |
Samsara BioCapital, LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| igm biosciences inc | -1,062,540 |
Samsara BioCapital, LLC got rid off the above stocks
Sector Distribution
Samsara BioCapital, LLC has about 63.1% of it's holdings in Others sector.
| Sector | % |
|---|---|
| Others | 63.1 |
| Healthcare | 36.9 |
Market Cap. Distribution
Samsara BioCapital, LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| UNALLOCATED | 63.1 |
| SMALL-CAP | 16.9 |
| MICRO-CAP | 10.4 |
| MID-CAP | 9.2 |
Stocks belong to which Index?
About 28.9% of the stocks held by Samsara BioCapital, LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 71.1 |
| RUSSELL 2000 | 28.9 |
Samsara BioCapital, LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Samsara BioCapital, LLC
Samsara BioCapital, LLC has 42 stocks in it's portfolio. About 74.3% of the portfolio is in top 10 stocks. HLVX proved to be the most loss making stock for the portfolio. ACLX was the most profitable stock for Samsara BioCapital, LLC last quarter.
Last Reported on: 14 Nov, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ACLX | arcellx inc | 5.68 | 353,641 | 29,532,600 | reduced | -22.04 | ||
| ACRS | aclaris therapeutics inc | 0.15 | 696,171 | 800,597 | unchanged | 0.00 | ||
| ALLK | allakos inc | 0.02 | 172,089 | 112,409 | unchanged | 0.00 | ||
| ALVR | allovir inc | 0.01 | 82,336 | 66,569 | unchanged | 0.00 | ||
| BOLT | bolt biotherapeutics inc | 0.13 | 1,049,150 | 679,851 | unchanged | 0.00 | ||
| DAWN | day one biopharmaceuticals i | 0.39 | 147,319 | 2,052,150 | reduced | -25.00 | ||
| ELYM | eliem therapeutics inc | 2.55 | 2,609,110 | 13,280,400 | reduced | -20.00 | ||
| GOSS | gossamer bio inc | 1.16 | 6,130,270 | 6,046,900 | unchanged | 0.00 | ||
| HLVX | hillevax inc | 0.27 | 799,274 | 1,406,720 | unchanged | 0.00 | ||
| IGMS | igm biosciences inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| INZY | inozyme pharma inc | 1.57 | 1,562,500 | 8,171,880 | unchanged | 0.00 | ||
| IOBT | io biotech inc | 0.74 | 3,640,020 | 3,822,020 | unchanged | 0.00 | ||
| JANX | janux therapeutics inc | 0.20 | 22,526 | 1,023,360 | reduced | -50.00 | ||
| JSPR | jasper therapeutics inc | 2.11 | 584,642 | 10,997,100 | added | 11.36 | ||
| KRON | kronos bio inc | 0.01 | 78,131 | 78,123 | unchanged | 0.00 | ||
| LPTX | leap therapeutics inc | 1.21 | 2,442,350 | 6,276,840 | unchanged | 0.00 | ||
| LYRA | lyra therapeutics inc | 0.14 | 2,780,260 | 714,527 | unchanged | 0.00 | ||
| NKTX | nkarta inc | 3.27 | 3,768,040 | 17,031,500 | unchanged | 0.00 | ||
| NUVB | nuvation bio inc | 0.00 | 133,333 | 13,053 | unchanged | 0.00 | ||
| RYTM | rhythm pharmaceuticals inc | 1.74 | 172,647 | 9,044,980 | unchanged | 0.00 | ||